Paranasal sinus adenoid cystic carcinoma
MONDO:0006352A rare adenoid cystic carcinoma that arises from the paranasal sinuses. It usually has an aggressive clinical course characterized by high recurrence rates and distant metastases.
Also known as: accessory sinus adenoid cystic carcinoma, adenoid cystic carcinoma of accessory sinus, adenoid cystic carcinoma of paranasal sinus, adenoid cystic carcinoma of the accessory sinus, adenoid cystic carcinoma of the paranasal sinus, paranasal sinus adenoid cystic carcinoma
2855 clinical trials for this condition and its sub-types, 5 tagged with Paranasal sinus adenoid cystic carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Paranasal sinus adenoid cystic carcinoma
-
New drug duo aims to make inoperable sinus cancer removable
Disease control Recruiting nowThis phase 2 trial tests a combination of two drugs—becotatug vedotin (a targeted antibody-drug conjugate) and epirubicin (a standard chemo)—in 40 people with EGFR-positive, recurrent sinonasal adenoid cystic carcinoma that cannot be surgically removed. The goal is to shrink the …
Phase 2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New chemo approach may spare sinus cancer patients from major surgery
Disease control Recruiting nowThis study is for people with a rare sinus cancer called sinonasal adenoid cystic carcinoma. The treatment delivers high-dose chemotherapy directly to the tumor through a small tube in an artery, aiming to shrink it as much as possible. After three sessions, doctors check if the …
Phase 2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Rare sinus cancer study aims to clarify treatment outcomes
Knowledge-focused Recruiting nowThis study follows people with a rare and advanced cancer of the nasal cavity and sinuses called T4 sinonasal adenoid cystic carcinoma. All participants receive the standard treatment: surgery followed by radiation therapy. The goal is to measure how long people live without the …
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC